Recursion Pharmaceuticals Inc (RXRX)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
Nov 01, 16:00
6.405
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap: 1.806B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.806B |
| October 31, 2024 | 1.784B |
| October 30, 2024 | 1.885B |
| October 29, 2024 | 1.902B |
| October 28, 2024 | 1.939B |
| October 25, 2024 | 1.829B |
| October 24, 2024 | 1.795B |
| October 23, 2024 | 1.787B |
| October 22, 2024 | 1.866B |
| October 21, 2024 | 1.908B |
| October 18, 2024 | 1.959B |
| October 17, 2024 | 1.849B |
| October 16, 2024 | 1.978B |
| October 15, 2024 | 1.883B |
| October 14, 2024 | 1.897B |
| October 11, 2024 | 1.868B |
| October 10, 2024 | 1.744B |
| October 09, 2024 | 1.736B |
| October 08, 2024 | 1.818B |
| October 07, 2024 | 1.744B |
| October 04, 2024 | 1.724B |
| October 03, 2024 | 1.710B |
| October 02, 2024 | 1.724B |
| October 01, 2024 | 1.741B |
| September 30, 2024 | 1.860B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.970B |
| September 26, 2024 | 2.024B |
| September 25, 2024 | 1.945B |
| September 24, 2024 | 1.931B |
| September 23, 2024 | 1.883B |
| September 20, 2024 | 1.919B |
| September 19, 2024 | 1.959B |
| September 18, 2024 | 1.950B |
| September 17, 2024 | 1.908B |
| September 16, 2024 | 1.877B |
| September 13, 2024 | 1.854B |
| September 12, 2024 | 1.835B |
| September 11, 2024 | 1.820B |
| September 10, 2024 | 1.784B |
| September 09, 2024 | 1.727B |
| September 06, 2024 | 1.671B |
| September 05, 2024 | 1.741B |
| September 04, 2024 | 1.722B |
| September 03, 2024 | 1.713B |
| August 30, 2024 | 2.055B |
| August 29, 2024 | 2.091B |
| August 28, 2024 | 2.080B |
| August 27, 2024 | 2.148B |
| August 26, 2024 | 2.227B |
| August 23, 2024 | 2.204B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
866.92M
Minimum
May 11 2022
6.961B
Maximum
Jul 13 2021
2.294B
Average
1.899B
Median
Oct 11 2022
Market Cap Benchmarks
| Eli Lilly and Co | 777.42B |
| Pfizer Inc | 159.18B |
| Revance Therapeutics Inc | 604.25M |
| Twist Bioscience Corp | 2.435B |
| NovaBay Pharmaceuticals Inc | 3.664M |
Market Cap Related Metrics
| PS Ratio | 30.10 |
| PEG Ratio | -0.2071 |
| Price to Book Value | 3.091 |
| Price | 6.40 |
| Earnings Yield | -25.62% |
| PEGY Ratio | -0.2071 |